-
2023 COMB Conference | Professor Qiao Li : Current and Future Perspectives on Neoadjuvant Research for TNBC
Triple-negative breast cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer, accounting for 15% to 20% of all breast cancers. Compared to other subtypes, TNBC patients often experience rapid clinical progression, are diagnosed at a younger age, have faster distant recurrence, and more common visceral metastasis. Treatment for TNBC is usually limited…
-
Consensus on Targeted Prostate Biopsy at Panjiayuan by National Cancer Center
In recent years, the incidence and mortality rates of prostate cancer in China have been rapidly increasing. Early diagnosis and treatment are crucial, with prostate biopsy histopathology being the gold standard for diagnosis. However, differences in equipment and technical levels among medical institutions in China pose challenges for prostate biopsies, including issues with technique selection…
-
VLA-4 Agonists – Enhancing Hematopoietic Stem Cell Engraftment, Accelerating Immune Reconstitution, and Increasing Treatment Success Rates for Patient
Hematopoietic stem cell transplantation (HSCT) is an effective, and often the only, curative treatment for malignant hematological diseases such as leukemia. Key steps that impact the success of the transplantation include stem cell engraftment and the reconstitution of immune functions. From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation…
-
EBMT 2024 | Professor Qingxiao Song: PI3Kδ Inhibitors Show High Potential in the Treatment of cGVHD
Chronic graft-versus-host disease (cGVHD) is a clinical syndrome occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT), where the recipient’s organs are attacked by donor-derived lymphocytes during the reconstitution of the donor’s immune system. This includes both classic cGVHD and overlapping syndromes and is one of the main complications of transplantation, with an incidence rate of…
-
Professor Pizzi Interprets the 2023 ESC Endocarditis Guidelines Update at ESCMID Global 2024
Infective Endocarditis (IE) is a serious infectious cardiac condition. With advancements in medical technology, there have been significant changes in the diagnosis and treatment paradigms for IE. At the 34th European Congress of Clinical Microbiology & Infectious Diseases (ESCMID Global 2024), Infection Medicine Online had the privilege of interviewing Professor Maria Nazarena Pizzi from Vall…
-
Definition and Diagnostic Criteria for Acute-on-Chronic Liver Failure: An Eastern Perspective
The “Acute-on-Chronic Liver Failure (ACLF) Monthly Review” is a scholarly column produced by the Chinese Acute-on-Chronic Liver Failure Consortium at the invitation of the editorial department of the journal Liver International. Each month, the column focuses on a specific area of ACLF to disseminate knowledge about the concept and significance of ACLF and to help…
-
EBMT 2024 | Professor Linhua Yang: Embracing the Pulse of the Era, Focusing on the Advancements of Allogeneic Hematopoietic Stem Cell Transplantation and Cellular Immunotherapy in Hematologic Malignancies
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) annual meeting was grandly held in Glasgow, UK. The conference focused on the latest advancements in stem cell transplantation and cellular therapy, pushing forward better clinical outcomes for patients with blood diseases and hematologic malignancies. In this issue, we…
-
2023 COMB | Professor Fei Ma: The Knowns and Unknowns of Breast Cancer Immunotherapy
The 6th Precision Oncology Summit and the 9th Individualized Breast Cancer Treatment Conference (2023 COMB) took place from December 23 to 26, 2023, combining both online and offline formats. During the event, Professor Fei Ma from the Cancer Hospital of the Chinese Academy of Medical Sciences delivered an insightful presentation titled “The Knowns and Unknowns…
Connecting Medical Expertise through Media